AMCA
Arthur M. Cohen & Associates’s Vertex Pharmaceuticals VRTX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $396K | Hold |
890
| – | – | 0.07% | 95 |
|
|
2025
Q1 | $431K | Hold |
890
| – | – | 0.08% | 85 |
|
|
2024
Q4 | $358K | Buy |
890
+30
| +3% | +$12.1K | 0.06% | 106 |
|
|
2024
Q3 | $404K | Hold |
860
| – | – | 0.07% | 94 |
|
|
2024
Q2 | $403K | Buy |
860
+60
| +8% | +$28.1K | 0.07% | 97 |
|
|
2024
Q1 | $334K | Hold |
800
| – | – | 0.07% | 104 |
|
|
2023
Q4 | $326K | Buy |
800
+25
| +3% | +$10.2K | 0.08% | 103 |
|
|
2023
Q3 | $269K | Hold |
775
| – | – | 0.07% | 108 |
|
|
2023
Q2 | $273K | Hold |
775
| – | – | 0.07% | 109 |
|
|
2023
Q1 | $244K | Buy |
+775
| New | +$244K | 0.07% | 112 |
|
|
2022
Q4 | – | Sell |
-775
| Closed | -$224K | – | 133 |
|
|
2022
Q3 | $224K | Hold |
775
| – | – | 0.06% | 115 |
|
|
2022
Q2 | $202K | Hold |
775
| – | – | 0.05% | 126 |
|
|
2022
Q1 | $202K | Buy |
+775
| New | +$202K | 0.04% | 136 |
|
|
2020
Q4 | – | Sell |
-830
| Closed | -$226K | – | 150 |
|
|
2020
Q3 | $226K | Hold |
830
| – | – | 0.06% | 128 |
|
|
2020
Q2 | $241K | Buy |
+830
| New | +$241K | 0.07% | 110 |
|